Lilly Zyprexa Efficacy In Bipolar Mixed Mania May Be Highlighted By Firm
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Zyprexa (olanzapine) effectiveness in bipolar disorder (BPD) patients with mixed mania and rapid cycling could be one of the features that Lilly highlights in promoting the new indication for its antipsychotic drug.